Rinsing to reduce eye inflammation in dry eye disease
Part of Eyes & vision clinical trials.
This study tests whether rinsing the eye surface helps reduce inflammation and symptoms in people with dry eyes. Participants must have a specific inflammatory marker (MMP-9) in both eyes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed MMP-9 marker (an inflammation sign) in both eyes
- No active eye infections (bacterial, viral, or fungal) or severe allergic eye reactions right now
- No history of autoimmune eye diseases like Sjögren syndrome or Stevens-Johnson syndrome
- Haven't used anti-inflammatory eye drops (steroids, cyclosporine, lifitegrast, or NSAIDs) in the past 2–4 weeks
- No eye surgery or laser treatment in the past 3–6 months
- Haven't worn contact lenses in the past 12–24 hours before screening tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Xiidra eye drops affect natural tear markers in people with dry eye. It also compares them to a small group of people without dry eye. If you have moderate dry eye and are already using Xiidra (or you do not have dry eye and want to help as a volunteer), you may be able to join.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study tests whether lifitegrast eye drops (a medication that reduces eye inflammation) help people with moderate to severe dry eye disease. Researchers will use a special microscope to examine your eye surface before and after treatment.
This trial studies how to treat eye surface discomfort in people who have glaucoma and are already using multiple eye drops. It may help reduce symptoms like irritation while keeping glaucoma treatment on track.
This study tests an eye drop to help stabilize the natural tear film on the surface of the eye. It may help people who have normal tear production but could benefit from better tear film stability.
This trial tests whether an eye drop version of infliximab, a medication that reduces inflammation, can help people with Sjögren's syndrome who have severe dry eye. You would keep taking your current medications and add these drops to see if they improve symptoms and eye surface damage.
Hear when a new Dry Eye Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.